CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma
Liying Ren(Guilin Medical University), Weijia Liao(Guilin Medical University), Bigeng Zhao(Guilin Medical University), Rongyu Wei(Guilin Medical University), Yuanping Zhou(Guangdong Medical College), Hongsong Chen(Inner Mongolia University for Nationalities), Yong He(Second Affiliated Hospital of Zhejiang University), Tingfeng Xu(Guilin Medical University), Minjun Liao(Guilin Medical University), Dongbo Chen(Diponegoro University)
Cited by 2
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118